Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

Bibliographic Details
Main Authors: Y Chen, P Jobanputra, P Barton, S Bryan, A Fry-Smith, G Harris, R Taylor
Format: Article
Language:English
Published: NIHR Journals Library 2008-04-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta12110

Internet

https://doi.org/10.3310/hta12110

Similar Items